Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.6986
-0.0099 (-1.40%)
At close: Jun 3, 2025, 4:00 PM
0.7089
+0.0103 (1.47%)
After-hours: Jun 3, 2025, 5:41 PM EDT

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $23.19 million as of June 3, 2025. Its market cap has decreased by -77.98% in one year.

Market Cap
23.19M
Enterprise Value
-3.92M
1-Year Change
-77.98%
Ranking
Category
Stock Price
$0.70

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has decreased from $56.60M to $23.19M, a decrease of -59.03%. That is a compound annual growth rate of -8.80%.

History

DateMarket Cap% Change
Jun 3, 202523.10M47.13%
Dec 31, 202415.70M-87.40%
Dec 29, 2023124.60M18.67%
Dec 30, 2022105.00M-73.42%
Dec 31, 2021395.00M-24.17%
Dec 31, 2020520.90M30.00%
Dec 31, 2019400.70M1,125.38%
Dec 31, 201832.70M247.87%
Dec 29, 20179.40M-28.24%
Dec 30, 201613.10M-54.67%
Dec 31, 201528.90M-48.94%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 670.72B
Johnson & Johnson 373.90B
AbbVie 330.30B
Novo Nordisk 323.14B
UnitedHealth Group 276.42B
Abbott Laboratories 232.39B
Novartis AG 228.01B
AstraZeneca 222.18B
Market Cap Rankings